Biotechnology
News Category
VERAXA Biotech Advances Lead BiTAC T-Cell Engager Program With Cell Line Development Partnership
VERAXA Biotech has initiated cell line development for its lead BiTAC T-cell engager program, selecting ATUM to support manufacturing as it advances t...
Quantum BioPharma Ltd. Emerges as a Key Player in Neurodegenerative and Metabolic Disorder Therapies
Quantum BioPharma's diversified platform, including clinical-stage therapeutics and consumer wellness products, positions it to address significant un...
Ocumetics Advances Vision Restoration Technology with Positive Six-Month Clinical Results and Commencement of Next-Generation Lens Manufacturing
Ocumetics Technology Corp. reports positive six-month data from its First-in-Human study, advancing to Group Two surgeries with a redesigned intraocul...
Oncotelic Launches AI-Powered GMP Manufacturing Platform to Address Biotech Bottleneck
Oncotelic Therapeutics announced an AI-driven GMP manufacturing services platform that leverages its PDAOAI architecture and robotics to help emerging...
Greenland Mines Advances Skaergaard Project with Development Planning Workshop
Greenland Mines Ltd (NASDAQ: GRML) held a three-day development planning workshop with international specialists to advance its Skaergaard project, hi...
VERAXA Biotech Advances Lead BiTAC T-Cell Engager Program with Cell Line Development Partnership
VERAXA Biotech has initiated cell line development for its lead BiTAC T-cell engager program by partnering with ATUM, marking a key milestone toward I...
NanoViricides Receives Outperform Rating and $6 Price Target from Noble Capital Markets
NanoViricides initiates coverage with an Outperform rating and $6 price target from Noble Capital Markets, highlighting the potential of its broad-spe...
NanoViricides Receives Outperform Rating and $6 Price Target from Noble Capital Markets
Independent analyst Robert LeBoyer of Noble Capital Markets initiated coverage of NanoViricides with an Outperform rating and $6 price target, highlig...
Lantern Pharma Launches ZetaOmics, an AI-Powered Computational Biology Platform for Precision Oncology
Lantern Pharma's launch of ZetaOmics, an autonomous computational biologist agent within its withZeta.ai platform, aims to automate multi-omic analysi...
VERAXA Biotech Stands to Benefit from Novartis' $1.5B ADC Acquisition
Novartis' acquisition of Myricx Bio for $1.5 billion underscores the surging demand for next-generation antibody-drug conjugates, a sector where VERAX...
Oncotelic Therapeutics Reports Positive Safety Review for Sapu003 Phase 1b Trial, Plans European Expansion
Oncotelic announced that its Phase 1b trial of Sapu003 passed initial safety review with no dose-limiting toxicities, enabling dose escalation and exp...
Oragenics Activates All Australian Phase IIa Trial Sites for Concussion Drug ONP-002
Oragenics has activated all three Australian sites for its Phase IIa trial of ONP-002 for mild traumatic brain injury, with no serious adverse events ...
VolitionRx Study Demonstrates Prognostic Value of Nu.Q Cancer Assay in Lung Cancer, Paving Way for Personalized Treatment
A new clinical study by VolitionRx shows that its Nu.Q Cancer Assay's H3K27Me3-nucleosome biomarker can predict survival outcomes in newly diagnosed l...
RockBreaks – Greenland Mines Ltd Adds Two Geologists to 2026 Skaergaard Field Campaign
Greenland Mines Ltd strengthens its technical team by adding two prominent geologists to its 2026 Skaergaard campaign in Greenland, enhancing expertis...
Sustained Release Polymers Market Set to Reach USD 7.8 Billion by 2036, Driven by Chronic Disease Management and Drug Delivery Innovation
The global sustained release polymers market is projected to grow from USD 3.8 billion in 2026 to USD 7.8 billion by 2036 at a CAGR of 7.4%, driven by...
VERAXA Biotech Highlights BiTAC Pipeline Progress and Partnering Strategy
VERAXA Biotech updates on its BiTAC platform advancement and strategic partnering efforts, aiming to advance lead candidate VXA-102 to IND/CTA readine...
The New Rules of Biotech Now Available in Hardcover and Audiobook
David Craig's book 'The New Rules of Biotech' offers a modern guide for building biotech companies in today's capital-constrained environment, now rel...
VERAXA Biotech Positioned in Active ADC Market After Novartis' $1.5B Myricx Bio Acquisition
Novartis' $1.5 billion acquisition of Myricx Bio underscores strong pharmaceutical demand for next-generation ADC technologies, highlighting VERAXA Bi...
VERAXA Biotech Advances BiTAC Pipeline and Partnering Strategy in First Half of 2026
VERAXA Biotech AG reports progress in its BiTAC platform with four T-cell engager programs targeting solid tumors, plans to prioritize BiTAC developme...
VERAXA Biotech Reports BiTAC Pipeline Progress and Advances Partnering Strategy
VERAXA Biotech AG provided a corporate update highlighting its BiTAC platform progress, four T-cell engager programs, and growing pharmaceutical partn...
VERAXA Biotech Initiates Cell Line Development for Lead BiTAC Cancer Therapy Program
VERAXA Biotech has begun cell line development for its lead BiTAC T-cell engager program through a collaboration with ATUM, aiming to advance a novel ...
Gut Microbiome Key to Immunotherapy Success in Liver Cancer, Review Finds
A comprehensive review reveals that the gut microbiome significantly influences how liver cancer patients respond to immunotherapy, potentially enhanc...
LIXTE Biotechnology Completes Merger with NOMAD, Rebrands as NOMAD Power Solutions to Focus on Energy Storage
LIXTE Biotechnology Holdings has completed its merger with NOMAD Transportable Power Systems, changing its name to NOMAD Power Solutions and shifting ...
VERAXA Biotech Initiates Cell Line Development for Lead BiTAC Cancer Therapy Program
VERAXA Biotech has started cell line development for its lead BiTAC T-cell engager program through a collaboration with ATUM, aiming to enhance tumor ...
VERAXA Biotech's Platform Positions It in Active Antibody Therapeutics Deal Landscape
Strategic licensing and acquisition activity in antibody-drug conjugates and T-cell engagers highlights the value of early-stage platforms, with VERAX...
Quantum BioPharma Executive Discusses MS Drug Candidate and Growth Strategy on BioMedWire Podcast
Quantum BioPharma's executive co-chairman Anthony Durkacz appeared on the BioMedWire Podcast to detail the company's strategy for advancing its multip...
Antibody Therapeutics Sector Deal Activity Highlights Value of Early-Stage Innovation, VERAXA Biotech Positioned to Benefit
The article discusses sustained deal activity in antibody-drug conjugates (ADCs) and T-cell engagers, noting that pharmaceutical companies are committ...
MindBio Therapeutics Delivers First Edge AI Intoxication Detection Kiosk Prototypes for Workplace Safety
MindBio Therapeutics has completed and delivered its first prototype Edge AI Intoxication and Fatigue Detection Kiosks, leveraging voice analysis and ...
Quantum BioPharma Highlights MS Drug Candidate and Growth Strategy in Executive Podcast
Quantum BioPharma's executive co-chairman discusses the company's lead multiple sclerosis drug candidate Lucid-MS and its alcohol metabolism accelerat...
Annovis Bio Promotes Cheng Fang to Chief Scientific Officer as Key Alzheimer's Trial Nears Data Readout
Annovis Bio promotes Dr. Cheng Fang to CSO to lead scientific strategy as the company approaches pivotal Phase 3 Alzheimer's data and NDA submission f...
Onco-Innovations Announces CAD$5 Million Private Placement to Advance Oncology Programs
Onco-Innovations Limited has signed a term sheet for a CAD$5 million private placement with institutional investors, with proceeds aimed at developing...
Onco-Innovations Advances ONC010 Manufacturing Development With Nanosoft Collaboration
Onco-Innovations Limited partners with Nanosoft Polymers to optimize polymer synthesis and analytical characterization for its lead nanoparticle-formu...
GeoVax Highlights Continued U.S. Government Investment in Orthopox Preparedness as Strategic Validation of Long-Term Vaccine Readiness
GeoVax comments on recent U.S. government procurement of smallpox vaccine, reinforcing the strategic importance of sustained investment in domestic or...
Active Hybrid Humidification Incubator Market Projected to Reach USD 229.2 Million by 2036, Driven by Advanced Cell Culture Demands
The active hybrid humidification incubator market is expected to grow from USD 90 million in 2026 to USD 229.2 million by 2036 at a 9.8% CAGR, fueled ...
Helix BioPharma Corp. Strengthens Executive Leadership to Support U.S. Listing Strategy and Next Phase of Clinical Development
Helix BioPharma appoints Helen Middleton as General Counsel and David Browning as VP of Clinical Operations to bolster its leadership team ahead of a ...
HeartBeam Completes Patient Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study
HeartBeam (NASDAQ: BEAT) announced it has completed enrollment in its ALIGN-ACS pilot study evaluating the HeartBeam System for heart attack detection...
Cardio Diagnostics Holdings Leverages Epigenetics to Reveal Hidden Heart Disease Risks
Cardio Diagnostics Holdings (CDIO) uses epigenetics to uncover heart disease risks beyond genetics, offering insights into lifestyle and environmental...
TechForce Robotics Expands RaaS Platform into Pharmaceutical Laboratory Automation
TechForce Robotics has deployed its LIM-E autonomous laboratory robot at Oncotelic Therapeutics, marking its entry into lab automation, with a strateg...
Silo Pharma Advances SPC-15 Intranasal PTSD Program With Device Robustness Study
Silo Pharma announced a robustness study for its SPC-15 intranasal PTSD treatment delivery system, supporting regulatory guidance and Phase 1 trial pl...
Onco-Innovations Advances Manufacturing of Novel PNKP Inhibitor for Hard-to-Treat Cancers
Onco-Innovations Ltd. is developing a new class of DNA damage response therapies targeting PNKP, with a key manufacturing milestone achieved for its l...
Creative Enzymes Launches AI-Integrated Biocatalysis Platform to Accelerate Enzyme Development
Creative Enzymes' new AI-integrated platform accelerates enzyme development by merging computational design with practical process engineering, reduci...
Creative Biolabs Announces Custom Oligosaccharide Synthesis and Glycan Characterization Services to Accelerate Drug Discovery
Creative Biolabs integrates advanced synthesis technologies with comprehensive glycan analysis to provide structurally validated oligosaccharides, add...
Amerigo Scientific Launches High-Purity iPSC-Derived Cells to Advance Biomedical Research and Cell Therapy
Amerigo Scientific released high-quality iPSC-derived cells and engineered reporter cells, offering robust tools for disease modeling, drug screening,...
Quantum BioPharma Reaches Key Midpoint Milestone in Multiple Sclerosis Imaging Study
Quantum BioPharma announced its collaborative imaging study with Massachusetts General Hospital has reached the halfway point in patient enrollment, w...
SUIC and VisionRenu Sign Strategic MOU to Accelerate AI Biotechnology and Precision Medicine
SUIC Worldwide Holdings and VisionRenu Biomedical Technology have signed a strategic MOU to collaborate on AI-powered biotechnology, precision medicin...
Cardio Diagnostics Leverages Epigenetics to Uncover Hidden Heart Disease Risks
Cardio Diagnostics Holdings uses epigenetics to assess cardiovascular risk beyond genetic predisposition, offering insights into how lifestyle and env...
Oncotelic Therapeutics Announces Peer-Reviewed Validation of Deciparticle Platform in International Journal of Molecular Sciences
Oncotelic Therapeutics published a peer-reviewed manuscript validating its Deciparticle nanoparticle platform, which enables intravenous delivery of p...
Tonix Pharmaceuticals Enrolls First Patient in Phase 2 Trial of TNX-102 SL for Major Depressive Disorder
Tonix Pharmaceuticals has initiated a Phase 2 trial of TNX-102 SL as a first-line monotherapy for major depressive disorder, potentially offering a ne...